Back to Search
JACOB SPROUSE, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1275974677Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
14234(SC)
Research & Publications (20)
Inhibition of casein kinase I epsilon/delta produces phase shifts in the circadian rhythms of Cynomolgus monkeys.
PMID 19277609·Psychopharmacology (Berl)·2009
7-preclinical
Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing.
PMID 16631132·Biol Psychiatry·2006
7-preclinical
Thrombogenic alleles, Escherichia coli O157:H7 infections, and hemolytic uremic syndrome.
PMID 11460012·Blood Coagul Fibrinolysis·2001
8-other
Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors.
PMID 19166502·J Neurochem·2009
7-preclinical
NAN-190 potentiates the circadian response to light and speeds re-entrainment to advanced light cycles.
PMID 18538936·Neuroscience·2008
7-preclinical
2-aryloxy-4-alkylaminopyridines: discovery of novel corticotropin-releasing factor 1 antagonists.
PMID 18288792·J Med Chem·2008
7-preclinical
Synthesis and SAR of 2-aryloxy-4-alkoxy-pyridines as potent orally active corticotropin-releasing factor 1 receptor antagonists.
PMID 18260619·J Med Chem·2008
7-preclinical
An inhibitor of casein kinase I epsilon induces phase delays in circadian rhythms under free-running and entrained conditions.
PMID 17502429·J Pharmacol Exp Ther·2007
7-preclinical
Circadian rhythm phenotype of 5-HT7 receptor knockout mice: 5-HT and 8-OH-DPAT-induced phase advances of SCN neuronal firing.
PMID 15834109·J Biol Rhythms·2005
7-preclinical
Novel 5-HT7 receptor inverse agonists. Synthesis and molecular modeling of arylpiperazine- and 1,2,3,4-tetrahydroisoquinoline-based arylsulfonamides.
PMID 15481983·J Med Chem·2004
7-preclinical
Serotonin-induced phase advances of SCN neuronal firing in vitro: a possible role for 5-HT5A receptors?
PMID 15352136·Synapse·2004
4-observational
Pharmacological modulation of circadian rhythms: a new drug target in psychotherapeutics.
PMID 14996616·Expert Opin Ther Targets·2004
6-review
8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production.
PMID 14654097·Neuropharmacology·2004
4-observational
Characterization of the 5-HT(7) receptor. Determination of the pharmacophore for 5-HT(7) receptor agonism and CoMFA-based modeling of the agonist binding site.
PMID 14640545·J Med Chem·2003
8-other
Elevated hemostatic factor levels as potential risk factors for thrombosis.
PMID 12421150·Arch Pathol Lab Med·2002
6-review
Temporary PSA rises and repeat prostate biopsies after brachytherapy.
PMID 11483330·Int J Radiat Oncol Biol Phys·2001
5-case
Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies.
PMID 11354013·Synapse·2001
7-preclinical
5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
PMID 10924666·Biol Psychiatry·2000
7-preclinical
T-cell clonality determination using polymerase chain reaction (PCR) amplification of the T-cell receptor gamma-chain gene and capillary electrophoresis of fluorescently labeled PCR products.
PMID 10874885·Am J Clin Pathol·2000
4-observational
5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus.
PMID 10862804·Biol Psychiatry·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1810 N HIGHWAY 17, WALGREEN'S #7156
MT PLEASANT, SC 29464 - Phone
- (843) 388-2585
Quick Facts
- NPI
- 1275974677
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile